Somatic Cancer Mutations in the SUV420H1 Protein Lysine Methyltransferase Modulate Its Catalytic Activity

• Published in: Journal of molecular biology Vol. 431; no. 17; pp. 3068 - 3080
• Main Authors: Bröhm, Alexander, Elsawy, Hany, Rathert, Philipp, Kudithipudi, Srikanth, Schoch, Tabea, Schuhmacher, Maren Kirstin, Weirich, Sara, Jeltsch, Albert
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 09.08.2019
• Subjects: H4K20 methylation; histone methylation; protein lysine methylation; protein lysine methyltransferase; somatic cancer mutations; histone methylation; CD; BRD1; H4K20 methylation; PKMT; dko; GR; protein lysine methylation; protein lysine methyltransferase; somatic cancer mutations; AdoMet; MEF; Somatic cancer mutations; Protein lysine methylation; Protein lysine methyltransferase; Histone methylation
• DOI: 10.1016/j.jmb.2019.06.021
• ISSN: 0022-2836

SUV420H1 is a protein lysine methyltransferase that introduces di- and trimethylation of H4K20 and is frequently mutated in human cancers. We investigated the functional effects of eight somatic cancer mutations on SUV420H1 activity in vitro and in cells. One group of mutations (S255F, K258E, A269V) caused a reduction of the catalytic activity on peptide and nucleosome substrates. The mutated amino acids have putative roles in AdoMet binding and recognition of H4 residue D24. Group 2 mutations (E238V, D249N, E320K) caused a reduction of activity on peptide substrates, which was partially recovered when using nucleosomal substrates. The corresponding residues could have direct or indirect roles in peptide and AdoMet binding, but the effects of the mutations can be overcome by additional interactions between SUV420H1 and the nucleosome substrate. The third group of mutations (S283L, S304Y) showed enhanced activity with peptide substrates when compared with nucleosomal substrates, suggesting that these residues are involved in nucleosomal interaction or allosteric activation of SUV420H1 after nucleosome binding. Group 2 and 3 mutants highlight the role of nucleosomal contacts for SUV420H1 regulation in agreement with the high activity of this enzyme on nucleosomal substrates. Strikingly, seven of the somatic cancer mutations studied here led to a reduction of the catalytic activity of SUV420H1 in cells, suggesting that SUV420H1 activity might have a tumor suppressive function. This could be explained by the role of H4K20me2/3 in DNA repair, suggesting that loss or reduction of SUV420H1 activity could contribute to a mutator phenotype in cancer cells. [Display omitted]